Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.

Journal of diabetes and its complications - 1 Jan 2000

Navarro-González Juan F, Muros Mercedes, Mora-Fernández Carmen, Herrera Haridian, Meneses Beatriz, García Javier

Abstract excerpt

STATEMENTS OF THE PROBLEM: Diabetic nephropathy (DN) is the main cause of end-stage renal disease (ESRD). Renin-angiotensin system (RAS) blockade is the standard of care; however, a significant proportion of patients progress to ESRD. Pentoxifylline (PTF) possesses properties suggesting potential renoprotective efficacy. The aim of the Pentoxifylline for Renoprotection in Diabetic Nephropathy (PREDIAN) study is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albuminuria
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetic Nephropathies

Share to Glomerular Filtration Rate

Share to Hypertension

Share to Kidney Failure, Chronic

Share to Renin-Angiotensin System

Share to Severity of Illness Index

Source

Identifiers

PMID: 21144773
DOI: 10.1016/j.jdiacomp.2010.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.PMID 21144773Read ↗

Pentoxifylline Ameliorates Subclinical Atherosclerosis Progression in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Randomized Pilot TrialSemantic proximity Read ↗

Medicinal Plants and Phytochemicals used in Diabetic Nephropathy: A Comprehensive ReviewSemantic proximity Read ↗

Diabetic nephropathy.Semantic proximity Read ↗

PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanismsSemantic proximity Read ↗

WITHDRAWN: Spexin alleviates renal injury in streptozotocin induced diabetic nephropathy rat modelSemantic proximity Read ↗

[Emerging new aspects on diabetic nephropathy].Semantic proximity Read ↗

A Mathematical Model of Glomerular Fibrosis in Diabetic Kidney Disease to Predict Therapeutic EfficacySemantic proximity Read ↗

Association of genetic variants of pentraxin 3 rs3816527 with hypertension in Chronic kidney disease patients.Semantic proximity Read ↗

Protective Effects of <em>Phyllanthus emblica</em> L. Extract against Renal Dysfunction, Angiogenesis, and Fibrosis Occur through the Regulation of PKCα Activation, Vegf, and TGF-β1 in a Diabetic Nephropathy ModelSemantic proximity Read ↗

Ticagrelor Monotherapy in Patients with Concomitant Diabetes Mellitus and Chronic Kidney Disease: A post hoc analysis of the GLOBAL LEADERS TrialSemantic proximity Read ↗

[Diabetic nephropathy--predictive methods].Semantic proximity Read ↗

Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.